Search for: "AT&T Corp. v Service W., Inc." Results 421 - 440 of 516
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Feb 2008, 8:00 am
: (Spicy IP),Recent trends in IP strategy – an excerpt from London talk: (IP ThinkTank),World Customs Organisation recommends far-reaching new rules on IP: (Intellectual Property Watch),Members seek ways to move policy in WIPO Traditional Knowledge Committee: (Intellectual Property Watch)Global - Trade Marks / Domain Names / BrandsXerox – avoiding genericide: (Afro-IP),Big business urges adoption of Anti-Counterfeiting Treaty: (IP Justice),WIPO press release ‘Record… [read post]
5 Aug 2022, 5:01 am by Eugene Volokh
McClatchy Newspapers, Inc., 936 P.2d 1123, 1127 (Wash. 1997) [6] Id. at 1131, 1133. [7] Redgrave v. [read post]
13 Apr 2009, 4:00 am
Federal Express Corp., No. 07-10555 (5th Cir. [read post]
25 Jun 2023, 10:54 am by Eugene Volokh
Introduction Decisions not to buy or sell goods or services are generally not protected by the First Amendment. [read post]
29 Dec 2017, 7:34 am by Ben
But it wasn't just technology vs content: two major platforms, Spotify and Deezer, urged European legislators to ensure that the globally dominant giant US technology companies (primarily Apple, Amazon and Google) don't abuse their position as gatekeepers to digital consumers, not least as all three tech giants make and operate devices, control transaction platforms and own content services. [read post]
19 Dec 2016, 3:21 am by Peter Mahler
That’s not to say there aren’t common characteristics of such ownership contests. [read post]
14 Apr 2010, 2:13 pm by Adam Thierer
One much-discussed proposal would create a “public interest voucher” or what Robert W. [read post]
8 Apr 2021, 9:52 am by Eric Goldman
”  “[W]e assume, for argument’s sake, that the material [copied] was copyrightable. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]